ReviewFuture medicinal chemistry2025
Ribonucleotide reductase (RNR) inhibitors as target-based weapon for future cancer drug development.
Jaykumar Nagapara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it